Involvement of COX-1 in A3 adenosine receptor-mediated contraction through endothelium in mice aorta

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 293, Issue 6, 2007, Pages

  Ansari, Habib R ^a   Nadeem, Ahmed ^a   Tilley, Stephen L ^b   Mustafa, S Jamal ^a  

^a WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

A3 knockout; Contraction; Cyclooxygenases; Endothelium; Thromboxane A 2 pathway; Thromboxane prostanoid receptors

Indexed keywords

6 ETHYL 2 PHENYL 4 PROPYL 3 PYRIDINECARBOXYLIC ACID 5 THIOCARBOXYLIC ACID 5 ETHYL 3 PROPYL ESTER; ADENOSINE A3 RECEPTOR; CYCLOOXYGENASE 1; FUREGRELATE; SQ 29549; THROMBOXANE B2; THROMBOXANE RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG;

ANIMAL TISSUE; AORTA; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE EXPRESSION; HEART CONTRACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; VASCULAR ENDOTHELIUM; WESTERN BLOTTING;

ADENOSINE; ANIMALS; AORTA; BENZOFURANS; BLOTTING, WESTERN; CYCLOOXYGENASE 1; CYCLOOXYGENASE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; INDOMETHACIN; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; NITROBENZENES; POLYMERASE CHAIN REACTION; PYRAZOLES; PYRIDINES; RECEPTOR, ADENOSINE A3; RECEPTORS, THROMBOXANE; RNA, MESSENGER; SIGNAL TRANSDUCTION; SULFONAMIDES; THROMBOXANE B2; THROMBOXANE-A SYNTHASE; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS;

EID: 36849050373     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00764.2007     Document Type: Article

References (45)

1. 2B receptor-mediated vasorelaxation of mouse aorta. Am J Physiol Heart Circ Physiol 292: H719-H725, 2007.
2. Badier M, Soler M, Mallea M, Delpierre S, Orehek J. Cholinergic responsiveness of respiratory and vascular tissues in two different rat strains. J Appl Physiol 64:323-328, 1988.
3. Bolla M, You D, Loufrani L, Levy-Toledano S, Habib A, Henrion D. Cyclooxygenase involvement in thromboxane-dependent contraction in rat mesenteric resistance arteries. Hypertension 43: 1264-1269, 2004.
4. Bombardier C, Laine L, Reicin A, Shapiro D, Burgos-Vargas R, Davis B, Dar R, Ferraz MB, Hawkey CJ, Hochberg MC, Kvien TK, Schintzer TJ. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis VIGOR Study Group. N Engl J Med 343: 1520-1528, 2003.
5. Breyer MD, Breyer RM. G protein-coupled prostanoid receptors and the kidney. Annu Rev Physiol 63: 579-605, 2001.
6. Catella-Lawson F, Reilly MP, Kapoor SC, Cucchiara AJ, DeMarco S, Tournier B, Vyas SN, FitzGerald GA. Cyclooxygenase inhibitors and the antiplatelet effects of aspirin. N Engl J Med 345: 1809-1817, 2001.
7. Cipollone F, Fazia ML. COX-2 atherosclerosis. J Cardiovasc Pharmacol 47: S26-S36, 2006.
8. Cong P, Xiao Z, Biancani P, Behar J. Prostaglandins mediate tonic contraction of the guinea pig and human gallbladder. Am J Physiol Gastrointest Liver Physiol 292: G409-G418, 2007.
9. Elmhurst JL, Betti PA, Rangachari PK. Intestinal effects of isoprostanes: evidence for the involvement of prostanoid EP and TP receptors. J Pharmacol Exp Ther 282: 1198-1205, 1997.
10. 2 synthase in normal and LPS-primed lungs. Am J Physiol Lung Cell Mol Physiol 278: L744-L753, 2000.
11. Fan M, Qin W, Mustafa SJ. Characterization of adenosine receptor(s) involved in adenosine-induced branchoconstriction in an allergic mouse model. Am J Physiol Lung Cell Mol Physiol 284: L1012-L1019, 2003.
12. Feoktistov I, Ryzhov S, Goldstein AE, Biaggoni I. Mast cell-mediated stimulation of angiogenesis: cooperative interaction between A2B and A3 adenosine receptors. Circ Res 92: 485-492, 2003.
13. Furchgott RF, Vanhoutte PM. Endothelium-derived relaxing and contracting factors. FASEB J 3: 2007-2017, 1989.
14. Ge T, Vanhoutte PM, Boulanger CM. Increased response to prostaglandin H2 precedes changes in PGF-synthase 1 expression in the SHR aorta. Zhongguo Yao Li Xue Bao 20: 1087-1092, 1999.
15. 3 adenosine receptor. J Pharmacol Exp Ther 319: 1200-1210, 2006.
16. 2 receptor activation. Circ Res 81: 415-422, 1997.
17. 2 as endothelium-derived contracting factors. Am J Physiol Heart Circ Physiol 291: H2255-H2264, 2006.
18. +-ATPase. Pharmacol Toxicol 92: 265-271, 2003.
19. Greaves RR, O'Donnell LJ, Farthing MJ. Differential effect of prostaglandins on gallstone-free and gallstone-containing human gallbladder. Dig Dis Sci 45: 2376-2381, 2000.
20. Heymes C, Habib A, Yang D, Mathieu E, Marotte F, Samuel J, Boulanger CM. Cyclo-oxygenase-1 and -2 contributions to endothelial dysfunction in ageing. Br J Pharmacol 131: 804-810, 2000.
21. Ihara E, Hirano K, Derkach DN, Nishimura J, Nawata H, Kanaide H. The mechanism of bradykinin-induced endothelium-dependent contraction and relaxation in the porcine interlobar renal artery. Br J Pharmacol 129: 943-952, 2000.
22. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2[-delta delta C(T)] method. Methods 25: 402-408, 2001.
23. Matz RL, de Sotomayor MA, Schott C, Stoclet JC, Andriantsitohaina R. Vascular bed heterogeneity in age-related endothelial dysfunction with respect to NO and eicosanoids. Br J Pharmacol 131: 303-311, 2000.
24. Molero L, Carrasco C, Marques M, Vaziri ND, Mateos-Caceres PJ, Casado S, Macaya C, Barrientos A, Lopez-Farre AJ. Involvement of endothelium and endothelin-1 in lead-induced smooth muscle cell dysfunction in rats. Kidney Int 69: 685-690, 2006.
25. Potenza MA, Botrugno OA, DeSalvia MA, Lerro G, Nacci C, Marasciulo FL, Andriantsitohaina R, Mitolo-Cieppa D. Endothelial COX-1 and -2 differently affect reactivity of MVB in portal hypertensive rats. Am J Physiol Gastrointest Liver Physiol 283: G587-G594, 2002.
26. Qi Z, Hao CM, Langenbach RI, Breyer RM, Redha R, Morrow JD, Breyer MD. Opposite effects of cyclooxygenase-1 and -2 activity on the pressor response to angiotensin II. J Clin Invest 110: 61-69, 2002.
27. Qi Z, Cai H, Morrow JD, Breyer MD. Differentiation of cyclooxygenase 1- and 2-derived prostanoids in mouse kidney and aorta. Hypertension 48: 323-328, 2006.
28. 3 adenosine receptor gene in mice and its effect on stimulated inflammatory cells. J Biol Chem 275: 4429-4434, 2000.
29. Schiffrin EL. A critical review of the role of endothelial factors in the pathogenesis of hypertension. J Cardiovasc Pharmacol 38: S3-S6, 2001.
30. 3 adenosine receptor. Circ Res 78: 627-634, 1996.
31. Shirahase H, Murase K, Kanda M, Kurahashi K, Nakamura S. Endothelium-dependent contraction induced by substance P in canine cerebral arteries: involvement of NK1 receptors and thromboxane A2. Life Sci 64: 211-219, 1999.
32. Smith WL, DeWitt DL, Garavito RM. Cyclooxygenases: structural, cellular, and molecular biology. Annu Rev Biochem 69: 145-182, 2000.
33. Stanfield KM, Khan KN, Gralinski MR. Localization of cyclooxygenase isozymes in cardiovascular tissues of dogs treated with naproxen. Vet Immunol Immunopathol 80: 309-314, 2001.
34. Sullivan JC, Sasser JM, Pollock DM, Pollock JS. Sexual dimorphism in renal production of prostanoids in spontaneously hypertensive rats. Hypertension 45: 406-411, 2005.
35. Tabrizchi R, Bedi S. Pharmacology of adenosine receptors in the vasculature. Pharmacol Ther 91: 133-147, 2001.
36. 1 adenosine receptors in regulation of vascular tone. Am J Physiol Heart Circ Physiol 288: H1411-H1416, 2005.
37. 1 adenosine receptor in the regulation of coronary flow. Am J Physiol Heart Circ Physiol 291: H467-H472, 2006.
38. Thakali K, Davenport L, Fink GD, Watts SW. Cyclooxygenase, p38 MAPK, ERK MAPK, RHO kinase and SRC mediate hydrogen peroxide-induced contraction of rat thoracic aorta. J Pharmacol Exp Ther 320: 236-243, 2007.
39. Vanhoutte PM, Feletou M, Taddei S. Endothelium-dependent contractions in hypertension. Br J Pharmacol 144: 477-485, 2005.
40. Yang D, Feletou M, Boulanger CM, Wu HF, Levens N, Zhang JN, Vanhoutte PM. Oxygen-derived free radicals mediate endothelium dependent contractions to acetylecholine in aortas from spaontaneously hypertensive rats. Br J Pharmacol 136: 104-110, 2002.
41. Yang D, Feletou M, Levens N, Zhang JN, Vanhoutte PM. A diffusible substance(s) mediates endothelium-dependent contractions in the aorta of SHR. Hypertension 41: 143-148, 2003.
42. Zewde T, Mattson DL. Inhibition of cyclooxygenase-2 in the rat renal medualla leads to sodium-sensitive hypertension. Hypertension 44: 424-428, 2004.
43. 3 adenosine receptor in determining tissue levels of cAMP and blood pressure: studies in knock-out mice. Biochim Biophys Acta 1500: 280-90, 2000.
44. 3 adenosine receptor. Proc Natl Acad Sci USA 16: 7432-4736, 1992.
45. Zhou Y, Mitra S, Varadharaj S, Parinandi N, Zweier JL, Flavahan NA. Increased expression of cyclooxygenase-2 mediates enhanced contraction to endothelin ETA receptor stimulation in endothelial nitric oxide synthase knockout mice. Circ Res 98: 1439-1445, 2006.